Market Insights and MLB Valuations

This chapter examines the current state of the S&P 500, discussing investment strategies amidst market volatility and highlighting key performances of companies like Netflix and JP Morgan. It also introduces a significant FDA policy change related to drug development, exploring the potential of AI and organoid technology in the pharmaceutical industry. The discussion transitions to Major League Baseball, analyzing franchise valuations and the revenue dynamics of top teams like the Yankees and Dodgers.